Syntara Ltd logo

Syntara Ltd

ASX:SNT (Australia)  
A$ 0.02 (-4%) Jun 24
At Loss
P/B:
3.00
Market Cap:
A$ 28.66M ($ 19.05M)
Enterprise V:
A$ 23.42M ($ 15.57M)
Volume:
1.62M
Avg Vol (2M):
1.87M
Trade In:
Volume:
1.62M
At Loss
Avg Vol (2M):
1.87M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Syntara Ltd ( ASX:SNT ) from 2003 to Jun 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Syntara stock (ASX:SNT) PE ratio as of Jun 25 2024 is 0. More Details

Syntara Ltd (ASX:SNT) PE Ratio (TTM) Chart

To

Syntara Ltd (ASX:SNT) PE Ratio (TTM) Historical Data

Total 1293
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Syntara PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-25 At Loss 2024-04-23 At Loss
2024-06-24 At Loss 2024-04-22 At Loss
2024-06-21 At Loss 2024-04-19 At Loss
2024-06-20 At Loss 2024-04-18 At Loss
2024-06-19 At Loss 2024-04-17 At Loss
2024-06-18 At Loss 2024-04-16 At Loss
2024-06-17 At Loss 2024-04-15 At Loss
2024-06-14 At Loss 2024-04-12 At Loss
2024-06-13 At Loss 2024-04-11 At Loss
2024-06-12 At Loss 2024-04-10 At Loss
2024-06-11 At Loss 2024-04-09 At Loss
2024-06-10 At Loss 2024-04-08 At Loss
2024-06-07 At Loss 2024-04-05 At Loss
2024-06-06 At Loss 2024-04-04 At Loss
2024-06-05 At Loss 2024-04-03 At Loss
2024-06-04 At Loss 2024-04-02 At Loss
2024-06-03 At Loss 2024-04-01 At Loss
2024-05-31 At Loss 2024-03-29 At Loss
2024-05-30 At Loss 2024-03-28 At Loss
2024-05-29 At Loss 2024-03-27 At Loss
2024-05-28 At Loss 2024-03-26 At Loss
2024-05-27 At Loss 2024-03-25 At Loss
2024-05-24 At Loss 2024-03-22 At Loss
2024-05-23 At Loss 2024-03-21 At Loss
2024-05-22 At Loss 2024-03-20 At Loss
2024-05-21 At Loss 2024-03-19 At Loss
2024-05-20 At Loss 2024-03-18 At Loss
2024-05-17 At Loss 2024-03-15 At Loss
2024-05-16 At Loss 2024-03-14 At Loss
2024-05-15 At Loss 2024-03-13 At Loss
2024-05-14 At Loss 2024-03-12 At Loss
2024-05-13 At Loss 2024-03-11 At Loss
2024-05-10 At Loss 2024-03-08 At Loss
2024-05-09 At Loss 2024-03-07 At Loss
2024-05-08 At Loss 2024-03-06 At Loss
2024-05-07 At Loss 2024-03-05 At Loss
2024-05-06 At Loss 2024-03-04 At Loss
2024-05-03 At Loss 2024-03-01 At Loss
2024-05-02 At Loss 2024-02-29 At Loss
2024-05-01 At Loss 2024-02-28 At Loss
2024-04-30 At Loss 2024-02-27 At Loss
2024-04-29 At Loss 2024-02-26 At Loss
2024-04-26 At Loss 2024-02-23 At Loss
2024-04-25 At Loss 2024-02-22 At Loss
2024-04-24 At Loss 2024-02-21 At Loss

Syntara Ltd (ASX:SNT) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its world-leading expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis.